BDC-1001

Positive topline data for Bolt’s BDC-1001 in HER2 solid tumours
Clinical Trials Arena
Fri, 03/31/23 - 10:22 am
Bolt Biotherapeutics
BDC-1001
solid tumors
Roche
Bristol Myers Squibb